150 related articles for article (PubMed ID: 21396385)
1. Does possession of apolipoprotein E ɛ4 benefit cognitive function in healthy young adults?
Bunce D; Anstey KJ; Burns R; Christensen H; Easteal S
Neuropsychologia; 2011 Jun; 49(7):1693-7. PubMed ID: 21396385
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.
Batterham PJ; Bunce D; Cherbuin N; Christensen H
Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378
[TBL] [Abstract][Full Text] [Related]
3. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
4. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
[TBL] [Abstract][Full Text] [Related]
5. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
6. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G
J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and cognitive performance: a meta-analysis.
Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
[TBL] [Abstract][Full Text] [Related]
8. APOE genotype and cognitive change in young, middle-aged, and older adults living in the community.
Bunce D; Bielak AA; Anstey KJ; Cherbuin N; Batterham PJ; Easteal S
J Gerontol A Biol Sci Med Sci; 2014 Apr; 69(4):379-86. PubMed ID: 23902936
[TBL] [Abstract][Full Text] [Related]
9. APOE ε4 and cognitive function in early life: a meta-analysis.
Ihle A; Bunce D; Kliegel M
Neuropsychology; 2012 May; 26(3):267-77. PubMed ID: 22329498
[TBL] [Abstract][Full Text] [Related]
10. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
11. The apolipoprotein E gene and its age-specific effects on cognitive function.
Liu F; Pardo LM; Schuur M; Sanchez-Juan P; Isaacs A; Sleegers K; de Koning I; Zorkoltseva IV; Axenovich TI; Witteman JC; Janssens AC; van Swieten JC; Aulchenko YS; Oostra BA; van Duijn CM
Neurobiol Aging; 2010 Oct; 31(10):1831-3. PubMed ID: 19004527
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
[TBL] [Abstract][Full Text] [Related]
13. Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.
Du M; Andersen SL; Schupf N; Feitosa MF; Barker MS; Perls TT; Sebastiani P
J Alzheimers Dis; 2021; 79(1):117-125. PubMed ID: 33216038
[TBL] [Abstract][Full Text] [Related]
14. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
15. Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study.
Guo H; Tabara Y; Igase M; Yamamoto M; Ochi N; Kido T; Uetani E; Taguchi K; Miki T; Kohara K
Hypertens Res; 2010 Jan; 33(1):32-6. PubMed ID: 19851324
[TBL] [Abstract][Full Text] [Related]
16. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
17. Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III).
Obisesan TO; Umar N; Paluvoi N; Gillum RF
Clin Interv Aging; 2012; 7():35-43. PubMed ID: 22334766
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E epsilon4 and change in cognitive functioning in community-dwelling older adults.
Swan GE; Lessov-Schlaggar CN; Carmelli D; Schellenberg GD; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):196-201. PubMed ID: 16306239
[TBL] [Abstract][Full Text] [Related]
19. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
